AGRX - Agile Therapeutics beats by $0.04 March, 12 2019 04:28 PM Agile Therapeutics Inc. Agile Therapeutics (NASDAQ:AGRX): Q4 GAAP EPS of -$0.11 beats by $0.04. Cash and cash equivalents of $7.8M Press Release More news on: Agile Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,